Company Emphasis on Agentic AI:
M3 USA's engineering organization is committed to using agentic AI across the full engineering lifecycle, from planning and development through testing, deployment, and production operation. Engineers in this role use agentic coding with tools such as Claude Code and Codex, and apply generative AI to building systems, as a standard part of daily work. This includes reviewing what these tools produce: engineers are accountable for the correctness, quality, and security of AI-generated plans and code, and for curating the documentation and repository context that keep the tools effective over time. Active, daily use of agentic coding is a core expectation of the role.
Benefits:
A career opportunity with M3USA offers competitive wages, and benefits such as:
*M3 reserves the right to change this job description to meet the business needs of the organization
#LI-MM1
#LI-Remote
Job details are sourced from the employer's original posting.
Open job postingAbout the company
About m360 Research (m360 Research is a wholly owned subsidiary of M3) : m360 Research is a full-service market research agency specializing in the healthcare space. Our proprietary panels include over 1 million physicians across 75 specialties in addition to substantial communities of allied HCPs, and payers. Founded in 2004, with a strong provenance in technology and innovation, m360 is committed to high quality and actionable insights, underpinned by robust physician verification and ISO certification (9001, 20252, 27001). International fieldwork services are complemented by full service advanced analytics to power data-driven decision making. About M3: A Japanese global leader in the provision of ground-breaking and innovative technological and research solutions to the healthcare industry. The M3 Group operates in the US, Asia, and Europe with over 5.8 million physician members globally via its physician websites which include mdlinx.com, m3.com, research.m3.com, Doctors.net.uk, medigate.net, and medlive.cn. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413, NIKKEI 225) with subsidiaries in major markets including the US, UK, Japan, South Korea, and China, and in 2020 was ranked in Forbes’ Global 2000 list. The M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Japan, UK, France, Germany, Brazil, Sweden, China, USA, and South Korea, as well as India.